Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment.
Gerard AnmellaAlcy MeehanMelanie M AshtonMohammadreza MohebbiGiovanna FicoChee H NgMichael MaesLesley BerkMichele De PriscoAjeet B SinghGin S MalhiMichael BerkSeetal DoddDiego Hidalgo-MazzeiIria GrandeIsabella PacchiarottiAndrea MurruEduard VietaOlivia M DeanPublished in: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology (2023)
: Understanding the relationship between MDD and illness chronicity, comorbid systemic illness, and adverse effects, can potentially better characterise those individuals who are more likely to respond to adjunctive anti-inflammatory medications.